179 related articles for article (PubMed ID: 27749954)
1. Short-term Effects of High-Dose Caffeine on Cardiac Arrhythmias in Patients With Heart Failure: A Randomized Clinical Trial.
Zuchinali P; Souza GC; Pimentel M; Chemello D; Zimerman A; Giaretta V; Salamoni J; Fracasso B; Zimerman LI; Rohde LE
JAMA Intern Med; 2016 Dec; 176(12):1752-1759. PubMed ID: 27749954
[TBL] [Abstract][Full Text] [Related]
2. Caffeine restriction has no role in the management of patients with symptomatic idiopathic ventricular premature beats.
Newby DE; Neilson JM; Jarvie DR; Boon NA
Heart; 1996 Oct; 76(4):355-7. PubMed ID: 8983684
[TBL] [Abstract][Full Text] [Related]
3. Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing.
Bennett MT; Leader N; Sapp J; Parkash R; Gardner M; Healey JS; Thibault B; Sterns L; Essebag V; Birnie D; Sivakumaran S; Nery P; Andrade JG; Krahn AD; Tang A
Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005921. PubMed ID: 29618476
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
Kannankeril PJ; Moore JP; Cerrone M; Priori SG; Kertesz NJ; Ro PS; Batra AS; Kaufman ES; Fairbrother DL; Saarel EV; Etheridge SP; Kanter RJ; Carboni MP; Dzurik MV; Fountain D; Chen H; Ely EW; Roden DM; Knollmann BC
JAMA Cardiol; 2017 Jul; 2(7):759-766. PubMed ID: 28492868
[TBL] [Abstract][Full Text] [Related]
5. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
[TBL] [Abstract][Full Text] [Related]
6. Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.
Borlaug BA; Anstrom KJ; Lewis GD; Shah SJ; Levine JA; Koepp GA; Givertz MM; Felker GM; LeWinter MM; Mann DL; Margulies KB; Smith AL; Tang WHW; Whellan DJ; Chen HH; Davila-Roman VG; McNulty S; Desvigne-Nickens P; Hernandez AF; Braunwald E; Redfield MM;
JAMA; 2018 Nov; 320(17):1764-1773. PubMed ID: 30398602
[TBL] [Abstract][Full Text] [Related]
7. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
Edelmann F; Wachter R; Schmidt AG; Kraigher-Krainer E; Colantonio C; Kamke W; Duvinage A; Stahrenberg R; Durstewitz K; Löffler M; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Pieske B;
JAMA; 2013 Feb; 309(8):781-91. PubMed ID: 23443441
[TBL] [Abstract][Full Text] [Related]
8. Relationship of blood pressure, behavioral mood state, and physical activity following caffeine ingestion in younger and older women.
Arciero PJ; Ormsbee MJ
Appl Physiol Nutr Metab; 2009 Aug; 34(4):754-62. PubMed ID: 19767812
[TBL] [Abstract][Full Text] [Related]
9. Exercise training in heart failure with reduced ejection fraction and permanent atrial fibrillation: A randomized clinical trial.
Alves LS; Bocchi EA; Chizzola PR; Castro RE; Salemi VMC; de Melo MDT; Andreta CRL; Guimarães GV
Heart Rhythm; 2022 Jul; 19(7):1058-1066. PubMed ID: 35331961
[TBL] [Abstract][Full Text] [Related]
10. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic Function.
Aleong RG; Mulvahill MJ; Halder I; Carlson NE; Singh M; Bloom HL; Dudley SC; Ellinor PT; Shalaby A; Weiss R; Gutmann R; Sauer WH; Narayanan K; Chugh SS; Saba S; London B
J Am Heart Assoc; 2015 Jul; 4(8):e001566. PubMed ID: 26231842
[TBL] [Abstract][Full Text] [Related]
11. Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical Trial.
Hammond HK; Penny WF; Traverse JH; Henry TD; Watkins MW; Yancy CW; Sweis RN; Adler ED; Patel AN; Murray DR; Ross RS; Bhargava V; Maisel A; Barnard DD; Lai NC; Dalton ND; Lee ML; Narayan SM; Blanchard DG; Gao MH
JAMA Cardiol; 2016 May; 1(2):163-71. PubMed ID: 27437887
[TBL] [Abstract][Full Text] [Related]
12. Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study.
Gierula J; Lowry JE; Paton MF; Cole CA; Byrom R; Koshy AO; Chumun H; Kearney LC; Straw S; Bowen TS; Cubbon RM; Keenan AM; Stocken DD; Kearney MT; Witte KK
Circulation; 2020 May; 141(21):1693-1703. PubMed ID: 32299222
[TBL] [Abstract][Full Text] [Related]
13. Systolic Blood Pressure and Risk for Ventricular Arrhythmia in Patients With an Implantable Cardioverter Defibrillator.
Beinart R; Goldenberg I; Younis A; McNitt S; Huang D; Aktas MK; Spencer R; Kutyifa V; Nof E
Am J Cardiol; 2021 Mar; 143():74-79. PubMed ID: 33359194
[TBL] [Abstract][Full Text] [Related]
14. Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial.
Atchley AE; Kitzman DW; Whellan DJ; Iskandrian AE; Ellis SJ; Pagnanelli RA; Kao A; Abdul-Nour K; O'Connor CM; Ewald G; Kraus WE; Borges-Neto S;
Am Heart J; 2009 Oct; 158(4 Suppl):S53-63. PubMed ID: 19782789
[TBL] [Abstract][Full Text] [Related]
15. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
Tek M; Cavuşoğlu Y; Demirüstü C; Birdane A; Ünalır A; Görenek B; Göktekin Ö; Ata N
Turk Kardiyol Dern Ars; 2010 Jul; 38(5):334-40. PubMed ID: 21200103
[TBL] [Abstract][Full Text] [Related]
16. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.
Cleland JG; Teerlink JR; Senior R; Nifontov EM; Mc Murray JJ; Lang CC; Tsyrlin VA; Greenberg BH; Mayet J; Francis DP; Shaburishvili T; Monaghan M; Saltzberg M; Neyses L; Wasserman SM; Lee JH; Saikali KG; Clarke CP; Goldman JH; Wolff AA; Malik FI
Lancet; 2011 Aug; 378(9792):676-83. PubMed ID: 21856481
[TBL] [Abstract][Full Text] [Related]
17. Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits.
Pogwizd SM
Circulation; 1995 Aug; 92(4):1034-48. PubMed ID: 7543829
[TBL] [Abstract][Full Text] [Related]
18. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648
[TBL] [Abstract][Full Text] [Related]
19. Deceleration and Acceleration Capacities in Risk Stratification for Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease.
Buzea CA; Dan GA; Dan AR; Delcea C; Balea MI; Gologanu D; Popescu RA; Dobranici M
Am J Ther; 2017; 24(1):e44-e51. PubMed ID: 27148677
[TBL] [Abstract][Full Text] [Related]
20. Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction: A Substudy of the Empire HF Randomized Clinical Trial.
Omar M; Jensen J; Ali M; Frederiksen PH; Kistorp C; Videbæk L; Poulsen MK; Tuxen CD; Möller S; Gustafsson F; Køber L; Schou M; Møller JE
JAMA Cardiol; 2021 Jul; 6(7):836-840. PubMed ID: 33404637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
